A Study of Roginolisib (IOA-244) in Combination With Dostarlimab With or Without Docetaxel in Metastatic Non Small-cell Lung Cancer (NSCLC) Patients
A phase 1/2 trial of Dostarlimab, Docetaxel in non-small-cell lung cancer and small-cell lung cancer, run by iOnctura, active and no longer recruiting.
Overview
A Study of Roginolisib (IOA-244) in Combination With Dostarlimab With or Without Docetaxel in Metastatic Non Small-cell Lung Cancer (NSCLC) Patients is a phase 1/2 interventional study registered as NCT06879717 by iOnctura, with 45 participants planned, started 2025-04-22 and due to reach its primary completion in 2027-01. Interventions recorded: roginolisib, Dostarlimab, Docetaxel. Conditions listed: Non-Squamous Non-Small Cell Lung Cancer (NSCLC), Advanced Non Squamous NSCLC. No results are recorded here; the registry entry is the source.
Similar pages
not linked directly; found by shared links- TrialA Randomised Phase II Study of Roginolisib in Patients With Advanced/Metastatic Uveal Melanoma
Shares Roginolisib, iOnctura.
- TrialPhase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Acti
Shares Docetaxel, Small-cell lung cancer, Non-small-cell lung cancer.
- TrialStudy of Sacituzumab Govitecan (SG) Versus Docetaxel in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
Shares Docetaxel, Small-cell lung cancer, Non-small-cell lung cancer.
- TrialA Study Comparing BL-B01D1 With Docetaxel in Patients With Unresectable Locally Advanced or Metastatic EGFR Wild-type Non-small Cell Lung Cancer(PANKU
Shares Docetaxel, Small-cell lung cancer, Non-small-cell lung cancer.
- TrialIvonescimab in Combination With Docetaxel in Advanced Non-Small Cell Lung Cancer
Shares Docetaxel, Small-cell lung cancer, Non-small-cell lung cancer.
- TrialSafety and Preliminary Efficacy of Pumitamig (BNT327), an Investigational Therapy for Patients With Non-small Cell Lung Cancer in Combination With Che
Shares Docetaxel, Small-cell lung cancer, Non-small-cell lung cancer.
- TrialNelmastobart in Combination With Docetaxel in Non Small Cell Lung Cancer
Shares Docetaxel, Small-cell lung cancer, Non-small-cell lung cancer.
- TrialAssess Efficacy & Safety of Selumetinib in Combination With Docetaxel in Patients Receiving 2nd Line Treatment for v-Ki-ras2 Kirsten Rat Sarcoma Viral
Shares Docetaxel, Small-cell lung cancer, Non-small-cell lung cancer.